These compounds may interact with:
Sphingosine 1-phosphate receptor 3
Potentially involved in: carcinoma; multiple sclerosis; adult high grade glioma; astrocytoma; astrocytoma, pilocytic; atypical teratoid / rhabdoid tumor; breast cancer; ductal carcinoma in situ; ependymoma; glioblastoma; interstitial cystitis; intraductal papillary-mucinous adenoma (ipma); intraductal papillary-mucinous carcinoma (ipmc); intraductal papillary-mucinous neoplasm (ipmn); invasive ductal carcinoma; osteosarcoma; ovarian cancer; pancreatic cancer; pick disease; pituitary cancer
Disease data sourced from Pharos.